Please enable JavaScript to continue using this application.

Compare $ABOS vs $KRRO | Chartloom

Compare

$ABOS vs $KRRO

Acumen Pharmaceuticals Inc · Korro Bio Inc

ABOS

Acumen Pharmaceuticals Inc

KRRO

Korro Bio Inc

Compare $ABOS vs $KRRO

Comparing Acumen Pharmaceuticals Inc and Korro Bio Inc

ABOSAcumen Pharmaceuticals Inc

KRROKorro Bio Inc

ABOSAcumen Pharmaceuticals Inc

Market cap

$155M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

5.9%

52W performance

13.8%

FCF yield

-59.4%

KRROKorro Bio Inc

Market cap

$147M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

143.63x

Rev growth (TTM)

-62.1%

YTD performance

26.2%

52W performance

-77.8%

FCF yield

-46.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABOS

KRRO

Detailed metrics comparison

ABOS

Acumen Pharmaceuticals Inc

KRRO

Korro Bio Inc

Market Cap

ABOS$155M

KRRO$147M

Enterprise Value

ABOS$127M

KRRO$122M

Price

ABOS$2.14

KRRO$10.16

P/E Ratio

ABOSN/A

KRRON/A

P/S Ratio

ABOS102.45x

KRRO61.51x

EV/Sales

ABOS0.00x

KRRO51.05x

EV/EBITDA

ABOS0.00x

KRRO0.00x

P/B Ratio

ABOS2.58x

KRRO1.38x

P/FCF Ratio

ABOSN/A

KRRON/A

EV/FCF

ABOS-1.38x

KRRO-1.78x

PEG Ratio

ABOSN/A

KRRON/A

Forward P/E (NTM)

ABOSN/A

KRRON/A

Forward P/S (NTM)

ABOSN/A

KRRO143.63x

Revenue (TTM)

ABOS$0

KRRO$2M

Revenue Growth (YoY)

ABOSN/A

KRRO-62.1%

Forward Rev Growth

ABOS1135.7%

KRRO240.0%

Gross Margin (TTM)

ABOS0.0%

KRRO0.0%

Operating Margin (TTM)

ABOS0.0%

KRRO0.0%

EBITDA Margin (TTM)

ABOS0.0%

KRRO-3068.6%

Net Margin (TTM)

ABOS0.0%

KRRO-4477.1%

FCF Margin (TTM)

ABOSN/A

KRRO-2865.9%

Net Income (TTM)

ABOS$-105M

KRRO$-107M

FCF (TTM)

ABOS$-92M

KRRO$-68M

EPS (TTM)

ABOS-$1.45

KRRO-$6.05

ROE (TTM)

ABOS-13627.0%

KRRO-11426.0%

ROA (TTM)

ABOS-8164.0%

KRRO-6857.0%

ROIC (TTM)

ABOS-9709.0%

KRRO-11426.0%

Cash

ABOS$59M

KRRO$25M

Debt

ABOS$32M

KRRO$0

Net Cash/Debt

ABOS$28M

KRRO$25M

Current Ratio (TTM)

ABOS2.47x

KRRO9.55x

Quick Ratio (TTM)

ABOS2.38x

KRRO9.11x

Debt/Equity (TTM)

ABOS0.55x

KRRO0.00x

Debt/Assets (TTM)

ABOS0.0%

KRRO0.0%

Interest Coverage (TTM)

ABOSN/A

KRRON/A

Net Debt/EBITDA (TTM)

ABOS0.00x

KRRO0.00x

Beta

ABOS0.30

KRRO3.27

52W Performance

ABOS13.8%

KRRO-77.8%

YTD Performance

ABOS5.9%

KRRO26.2%

% from 52W High

ABOS-40.6%

KRRO-81.8%

% from 52W Low

ABOS42.7%

KRRO95.2%

Asset Turnover (TTM)

ABOS0.00x

KRRO0.04x

FCF Yield (TTM)

ABOS-59.4%

KRRO-46.6%

Earnings Yield (TTM)

ABOS-68.0%

KRRO-72.8%

Dividend Yield (TTM)

ABOSN/A

KRRON/A

Rule of 40

ABOS0.0

KRRO-2,927.9

EV/GP/RG

ABOSN/A

KRRON/A

Ticker research

View ABOS research View KRRO research

Metric	ABOS Acumen Pharmaceuticals Inc	KRRO Korro Bio Inc
Market & Valuation
Market Cap	$155M	$147M
Enterprise Value	$127M	$122M
Price	$2.14	$10.16
P/E Ratio	N/A	N/A
P/S Ratio	102.45x	61.51x
EV/Sales	0.00x	51.05x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.58x	1.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.38x	-1.78x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	143.63x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	-62.1%
Forward Rev Growth	1135.7%	240.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3068.6%
Net Margin (TTM)	0.0%	-4477.1%
FCF Margin (TTM)	N/A	-2865.9%
Net Income (TTM)	$-105M	$-107M
FCF (TTM)	$-92M	$-68M
EPS (TTM)	-$1.45	-$6.05
ROE (TTM)	-13627.0%	-11426.0%
ROA (TTM)	-8164.0%	-6857.0%
ROIC (TTM)	-9709.0%	-11426.0%
Financial Health
Cash	$59M	$25M
Debt	$32M	$0
Net Cash/Debt	$28M	$25M
Current Ratio (TTM)	2.47x	9.55x
Quick Ratio (TTM)	2.38x	9.11x
Debt/Equity (TTM)	0.55x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.30	3.27
52W Performance	13.8%	-77.8%
YTD Performance	5.9%	26.2%
% from 52W High	-40.6%	-81.8%
% from 52W Low	42.7%	95.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-59.4%	-46.6%
Earnings Yield (TTM)	-68.0%	-72.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-2,927.9
EV/GP/RG	N/A	N/A
Ticker research	View ABOS research	View KRRO research

Valuation

P/S Ratio

KRRO

61.51x

ABOS

102.45x

EV/FCF

KRRO

-1.78x

ABOS

-1.38x

Growth & revenue

Revenue Growth TTM

KRRO

-62.1%

Forward Revenue Growth

ABOS

1135.7%

KRRO

240.0%

Profitability & performance

Gross Margin

ABOS

0.0%

KRRO

0.0%

ROE

KRRO

-11426.0%

ABOS

-13627.0%

FCF Yield %

KRRO

-46.6%

ABOS

-59.4%

52-Week Performance

ABOS

13.8%

KRRO

-77.8%

Detailed metrics comparison

ABOS

Acumen Pharmaceuticals Inc

KRRO

Korro Bio Inc

Market Cap

ABOS$155M

KRRO$147M

Enterprise Value

ABOS$127M

KRRO$122M

Price

ABOS$2.14

KRRO$10.16

P/E Ratio

ABOSN/A

KRRON/A

P/S Ratio

ABOS102.45x

KRRO61.51x

EV/Sales

ABOS0.00x

KRRO51.05x

EV/EBITDA

ABOS0.00x

KRRO0.00x

P/B Ratio

ABOS2.58x

KRRO1.38x

P/FCF Ratio

ABOSN/A

KRRON/A

EV/FCF

ABOS-1.38x

KRRO-1.78x

PEG Ratio

ABOSN/A

KRRON/A

Forward P/E (NTM)

ABOSN/A

KRRON/A

Forward P/S (NTM)

ABOSN/A

KRRO143.63x

Revenue (TTM)

ABOS$0

KRRO$2M

Revenue Growth (YoY)

ABOSN/A

KRRO-62.1%

Forward Rev Growth

ABOS1135.7%

KRRO240.0%

Gross Margin (TTM)

ABOS0.0%

KRRO0.0%

Operating Margin (TTM)

ABOS0.0%

KRRO0.0%

EBITDA Margin (TTM)

ABOS0.0%

KRRO-3068.6%

Net Margin (TTM)

ABOS0.0%

KRRO-4477.1%

FCF Margin (TTM)

ABOSN/A

KRRO-2865.9%

Net Income (TTM)

ABOS$-105M

KRRO$-107M

FCF (TTM)

ABOS$-92M

KRRO$-68M

EPS (TTM)

ABOS-$1.45

KRRO-$6.05

ROE (TTM)

ABOS-13627.0%

KRRO-11426.0%

ROA (TTM)

ABOS-8164.0%

KRRO-6857.0%

ROIC (TTM)

ABOS-9709.0%

KRRO-11426.0%

Cash

ABOS$59M

KRRO$25M

Debt

ABOS$32M

KRRO$0

Net Cash/Debt

ABOS$28M

KRRO$25M

Current Ratio (TTM)

ABOS2.47x

KRRO9.55x

Quick Ratio (TTM)

ABOS2.38x

KRRO9.11x

Debt/Equity (TTM)

ABOS0.55x

KRRO0.00x

Debt/Assets (TTM)

ABOS0.0%

KRRO0.0%

Interest Coverage (TTM)

ABOSN/A

KRRON/A

Net Debt/EBITDA (TTM)

ABOS0.00x

KRRO0.00x

Beta

ABOS0.30

KRRO3.27

52W Performance

ABOS13.8%

KRRO-77.8%

YTD Performance

ABOS5.9%

KRRO26.2%

% from 52W High

ABOS-40.6%

KRRO-81.8%

% from 52W Low

ABOS42.7%

KRRO95.2%

Asset Turnover (TTM)

ABOS0.00x

KRRO0.04x

FCF Yield (TTM)

ABOS-59.4%

KRRO-46.6%

Earnings Yield (TTM)

ABOS-68.0%

KRRO-72.8%

Dividend Yield (TTM)

ABOSN/A

KRRON/A

Rule of 40

ABOS0.0

KRRO-2,927.9

EV/GP/RG

ABOSN/A

KRRON/A

Ticker research

View ABOS research View KRRO research

Metric	ABOS Acumen Pharmaceuticals Inc	KRRO Korro Bio Inc
Market & Valuation
Market Cap	$155M	$147M
Enterprise Value	$127M	$122M
Price	$2.14	$10.16
P/E Ratio	N/A	N/A
P/S Ratio	102.45x	61.51x
EV/Sales	0.00x	51.05x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.58x	1.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.38x	-1.78x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	143.63x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	-62.1%
Forward Rev Growth	1135.7%	240.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3068.6%
Net Margin (TTM)	0.0%	-4477.1%
FCF Margin (TTM)	N/A	-2865.9%
Net Income (TTM)	$-105M	$-107M
FCF (TTM)	$-92M	$-68M
EPS (TTM)	-$1.45	-$6.05
ROE (TTM)	-13627.0%	-11426.0%
ROA (TTM)	-8164.0%	-6857.0%
ROIC (TTM)	-9709.0%	-11426.0%
Financial Health
Cash	$59M	$25M
Debt	$32M	$0
Net Cash/Debt	$28M	$25M
Current Ratio (TTM)	2.47x	9.55x
Quick Ratio (TTM)	2.38x	9.11x
Debt/Equity (TTM)	0.55x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.30	3.27
52W Performance	13.8%	-77.8%
YTD Performance	5.9%	26.2%
% from 52W High	-40.6%	-81.8%
% from 52W Low	42.7%	95.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-59.4%	-46.6%
Earnings Yield (TTM)	-68.0%	-72.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-2,927.9
EV/GP/RG	N/A	N/A
Ticker research	View ABOS research	View KRRO research